|Articles|September 28, 2022
Emmes Acquires Clinical Edge
Company's fifth acquisition will advance its ophthalmology skillset and enhance global reach.
Advertisement
Emmes announced that it has acquired Clinical Edge. Clinical Edge trains and certifies visual function examiners at investigator sites conducting Phase I to IV ophthalmic clinical trials.
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will increase the origanization's skillsets in ophthalmic certification and training services.
Read more about the acquisition
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5